Truist Financial Cuts UnitedHealth Group (NYSE:UNH) Price Target to $610.00

UnitedHealth Group (NYSE:UNHFree Report) had its target price reduced by Truist Financial from $625.00 to $610.00 in a research report report published on Monday, Marketbeat Ratings reports. Truist Financial currently has a buy rating on the healthcare conglomerate’s stock.

UNH has been the subject of several other research reports. Cantor Fitzgerald boosted their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. TD Cowen boosted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Bank of America lowered their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Finally, Stephens boosted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $627.58.

View Our Latest Report on UNH

UnitedHealth Group Stock Up 1.9 %

UnitedHealth Group stock opened at $524.14 on Monday. UnitedHealth Group has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a 50 day moving average price of $557.00 and a 200 day moving average price of $561.46. The company has a market capitalization of $482.36 billion, a PE ratio of 34.15, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $6.56 EPS. Research analysts expect that UnitedHealth Group will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. UnitedHealth Group’s payout ratio is 54.72%.

Institutional Investors Weigh In On UnitedHealth Group

Institutional investors and hedge funds have recently made changes to their positions in the business. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group during the third quarter worth about $27,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in UnitedHealth Group during the third quarter worth about $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the third quarter worth about $37,000. Finally, Quarry LP grew its position in UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.